SAFETY AND EFFICACY OF LONG-TERM OPEN-LABEL DOSING OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)

被引：0
|
作者：
Bussel, J. [1 ]
Tarantino, M. [2 ]
Blanchette, V. [3 ]
Raj, A. [4 ]
Despotovic, J. [5 ]
Beam, D. [6 ]
Roy, J. [7 ,8 ]
Wang, X. [9 ]
Mehta, B. [9 ]
Eisen, M. [9 ]
机构：
[1] Weill Cornell Med, New York, NY USA
[2] Bleeding & Clotting Disorders Inst, Peoria, IL USA
[3] Hosp Sick Children, Toronto, ON, Canada
[4] Pediat Blood & Canc Disorders Clin, Louisville, KY USA
[5] Texas Childrens Hematol Ctr, Houston, TX USA
[6] Cook Childrens Med Ctr, Ft Worth, TX USA
[7] Childrens Hlth Queensland, St Lucia, Qld, Australia
[8] Pathol Queensland, St Lucia, Qld, Australia
[9] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P727
引用
收藏
页码：294 / 294
页数：1
相关论文
共 50 条
  • [41] Dose tapering to withdrawal stage and long-term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open-label extension study
    Mei, Heng
    Liu, Xiaofan
    Li, Yan
    Zhou, Hu
    Feng, Ying
    Gao, Guangxun
    Cheng, Peng
    Huang, Ruibin
    Yang, Linhua
    Hu, Jianda
    Hou, Ming
    Yao, Yazhou
    Liu, Li
    Wang, Yi
    Wu, Depei
    Zhang, Liansheng
    Zheng, Changcheng
    Shen, Xuliang
    Hu, Qi
    Liu, Jing
    Jin, Jie
    Luo, Jianmin
    Zeng, Yun
    Gao, Sujun
    Zhang, Xiaohui
    Zhou, Xin
    Shi, Qingzhi
    Xia, Ruixiang
    Xie, Xiaobao
    Jiang, Zhongxing
    Gao, Li
    Bai, Yuansong
    Xiong, Junye
    Li, Runzi
    Zou, Jianjun
    Niu, Ting
    Yang, Renchi
    Hu, Yu
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (03) : 716 - 728
  • [42] Long term safety and efficacy of open-label infliximab for SLE
    Aringer, M.
    Houssiau, F.
    Graninger, W. B.
    Feier, E.
    Steiner, G.
    Smolen, J. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 455 - 455
  • [43] An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP)
    Shirasugi, Yukari
    Ando, Kiyoshi
    Miyazaki, Koji
    Tomiyama, Yoshiaki
    Iwato, Koji
    Okamoto, Shinichiro
    Kurokawa, Mineo
    Kirito, Keita
    Hashino, Satoshi
    Ninomiya, Haruhiko
    Mori, Shinichiro
    Yonemura, Yuji
    Usuki, Kensuke
    Wei, Helen
    Lizambri, Richard
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 95 (06) : 652 - 659
  • [44] An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP)
    Yukari Shirasugi
    Kiyoshi Ando
    Koji Miyazaki
    Yoshiaki Tomiyama
    Koji Iwato
    Shinichiro Okamoto
    Mineo Kurokawa
    Keita Kirito
    Satoshi Hashino
    Haruhiko Ninomiya
    Shinichiro Mori
    Yuji Yonemura
    Kensuke Usuki
    Helen Wei
    Richard Lizambri
    International Journal of Hematology, 2012, 95 : 652 - 659
  • [45] Open-label, long-term safety study of zonisamide administered to children with epilepsy
    Shinnar, S
    Pellock, JM
    Conry, JA
    NEUROLOGY, 2006, 66 (05) : A37 - A37
  • [46] UPDATED RESULTS FROM THE SINGLE ARM, OPEN LABEL, LONG TERM EFFICACY/SAFETY OF SC ROMI IN ITP IN PEDS
    Bowers, Charles
    Grainger, John
    Bussel, James
    Tarantino, Michael
    Cooper, Nichola
    Beam, Donald
    Despotovic, Jenny
    Maschan, Alexey
    Wang, Kejia
    Eisen, Melissa
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S18 - S19
  • [47] The long-term efficacy of eltrombopag in children with immune thrombocytopenia
    Yang, Li-
    Sang, Bao-Hua
    Yang, Chun-Hui
    Xiao, Zu-Gang
    Fang, Chun-Lian
    Lv, Yu
    Li, Na
    Yang, Qing
    Chai, Shu-Min
    Tian, Xin
    Zhang, Xian-Wen
    Huang, Ti-Long
    ANNALS OF HEMATOLOGY, 2024, 103 (08) : 2721 - 2727
  • [48] An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia
    Gahan Pandina
    Stuart Kushner
    Keith Karcher
    Magali Haas
    Child and Adolescent Psychiatry and Mental Health, 6 (1)
  • [49] Open-label assessment of the long-term tolerability, safety, and efficacy of sertindole in patients with schizophrenia
    Hale, T.
    Murray, R. M.
    Azorin, J. M.
    Maehlum, E.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 431 - 432
  • [50] Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study
    Gevaert, Philippe
    Saenz, Rebecca
    Corren, Jonathan
    Han, Joseph K.
    Mullol, Joaquim
    Lee, Stella E.
    Ow, Randall A.
    Zhao, Rui
    Howard, Monet
    Wong, Kit
    Islam, Lutaf
    Ligueros-Saylan, Monica
    Omachi, Theodore A.
    Bachert, Claus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (03) : 957 - +
12345